Analyst Ratings for Momenta Pharmaceuticals (MNTA) [Buys]
MNTA Rating Summary
MNTA Price Target Summary
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$20.38 (+53.7%)
Avg. $ Target:
$20.38 (+53.7%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2012 | Bernstein | New Coverage | Outperform (N/A) |
24.00 (N/A) |
17.73 | 13.26 | -25.21% | Details |
| 8/5/2011 | Monness, Crespi, Hardt | Upgrade | Buy (N/A) |
25.00 (N/A) |
17.25 | 13.26 | -23.13% | Details |
| 11/20/2009 | Oppenheimer » Updated 8/4/2011 |
New Coverage | Outperform (N/A) |
24.00 (N/A) |
11.29 | 13.26 | 17.45% | Details |
